Agfa's Open Letter to De Tijd, Mediafin and De Persgroep

Agfa HealthCareDear Sir, I noted that De Tijd, and Bert Broens in particular, is continuing without abatement its 'damage Agfa-Gevaert' campaign. In recent months, we have noticed that this journalist continuously reports on Agfa-Gevaert in a one-sided negative manner and that he doesn't hesitate to publish inaccurate information.

The most striking examples were the articles published just before the General Meeting of Shareholders held in April. In these articles, he claimed that a number of important Agfa-Gevaert shareholders would vote against certain agenda items. When we checked this with our shareholders, the information turned out to be completely false. Templeton, our main shareholder, even felt forced to issue a press release to deny the content of the articles. In this case it is clear that even the most elementary rules of objective journalism were not observed.

Another example is a series of articles with completely false information about a possible operation involving Agfa Graphics. Insiders in the business know that this campaign was inspired by the management of Punch. I leave it to you to decide if this is ethically acceptable.

More recently, the campaign is aimed at Agfa HealthCare. This business group's important successes, such as the huge contract signed with the Paris hospitals, were minimized. In today's article some details were used to create a completely negative image.

It is obvious that we are not able to win every single contract. If that would be the case, we would hold a monopoly. Furthermore, it is only normal that occasionally a colleague leaves the company. It seems to me that this shouldn't be a reason for this type of negative coverage either.

Regarding this article, not a single contact was made with our company in order to at least check the accuracy of the information or to obtain additional information.

Again, I leave it to you to judge the quality of this kind of journalism.

I personally have put all means of communication at Bert Broens' disposal, my private mobile phone number included. I believe I can't do more than that.

Agfa-Gevaert is one of the few Belgian companies with very important global market shares in almost all of its activities. This goes for both our graphic and our healthcare business. Our competitors are therefore only too anxious to translate and spread this kind of articles amongst our customers.

Why a newspaper, which is presenting itself as the newspaper for the entrepreneurs in Flanders, is leading such a damaging campaign, goes beyond my comprehension.

It will therefore come to you as no surprise that I will demand - as a right to reply - the publication of a text from my hand, of comparable length in De Tijd.

In my opinion, this is the strict minimum that can be done to somewhat limit the significant economic damage created by this campaign.

Jo Cornu
CEO Agfa-Gevaert

Related news articles:

About Agfa
The Agfa-Gevaert Group is one of the world's leading imaging and information technology companies. Agfa develops, manufactures and markets analogue and digital systems for the printing industry (Agfa Graphics), the healthcare sector (Agfa HealthCare) and specific industrial applications (Agfa Materials). Agfa's headquarters are in Mortsel, Belgium. The company is present in 40 countries and has agents in another 100 countries throughout the world. The Agfa-Gevaert Group achieved a turnover of 3,283 million Euro in 2007.

About Agfa HealthCare
Agfa HealthCare, a member of the Agfa-Gevaert Group, is a leading provider of IT-enabled clinical workflow and diagnostic image management solutions, and state-of-the-art systems for capturing and processing images in hospitals and healthcare facilities. Agfa HealthCare has over a century of healthcare experience related to diagnostic imaging and has been a pioneer on the healthcare IT market since the early 1990's. The HealthCare division has sales offices and agents in over 100 markets worldwide. Sales for Agfa HealthCare in 2007 were 1,392 million Euro, accounting for 43% of total group sales. For more information on Agfa HealthCare, please visit www.agfa.com/healthcare.

Most Popular Now

Personalized Breast Cancer Prevention No…

A new telemedicine service for personalised breast cancer prevention has launched at preventcancer.co.uk. It allows women aged 30 to 75 across the UK to understand their risk of developing breast...

New App may Help Caregivers of People Ge…

A new study by investigators from Mass General Brigham showed that a new app they created can help improve the quality of life for caregivers of patients undergoing bone marrow...

An App to Detect Heart Attacks and Strok…

A potentially lifesaving new smartphone app can help people determine if they are suffering heart attacks or strokes and should seek medical attention, a clinical study suggests. The ECHAS app (Emergency...

A Machine Learning Tool for Diagnosing, …

Scientists aiming to advance cancer diagnostics have developed a machine learning tool that is able to identify metabolism-related molecular profile differences between patients with colorectal cancer and healthy people. The analysis...

Fine-Tuned LLMs Boost Error Detection in…

A type of artificial intelligence (AI) called fine-tuned large language models (LLMs) greatly enhances error detection in radiology reports, according to a new study published in Radiology, a journal of...

DeepSeek-R1 Offers Promising Potential t…

A joint research team from The Hong Kong University of Science and Technology and The Hong Kong University of Science and Technology (Guangzhou) has published a perspective article in MedComm...

New Research Finds Specific Learning Str…

If data used to train artificial intelligence models for medical applications, such as hospitals across the Greater Toronto Area, differs from the real-world data, it could lead to patient harm...

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

'AI Scientist' Suggests Combin…

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs - used to treat conditions such as high cholesterol and alcohol dependence...

Patients say "Yes..ish" to the…

As artificial intelligence (AI) continues to be integrated in healthcare, a new multinational study involving Aarhus University sheds light on how dental patients really feel about its growing role in...

Brains vs. Bytes: Study Compares Diagnos…

A University of Maine study compared how well artificial intelligence (AI) models and human clinicians handled complex or sensitive medical cases. The study published in the Journal of Health Organization...

New AI Transforms Radiology with Speed, …

A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology - boosting productivity, identifying life-threatening conditions in milliseconds and offering a breakthrough solution to the global radiologist...